about
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasisHLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.Analysis of HLA-ABC locus-specific transcription in normal tissues.Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.HLA class I antigen abnormalities and immune escape by malignant cells.The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.MHC class I antigens and immune surveillance in transformed cells.International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21High frequency of HLA-B44 allelic losses in human solid tumorsAnalysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanismsAnalysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumoursExpression of MHC class I, MHC class II, and cancer germline antigens in neuroblastomaAnalysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapyLOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomasCancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity
P50
Q28289791-48AF70A1-CE7C-43A3-A0C7-D9EFBC066604Q33451625-11681A35-C0B3-402E-ACC1-BCC7341C6B51Q33692969-8BA0C223-BABD-44C0-ABD8-0B271CE16191Q34583210-6DEA2B08-2917-45AC-8ED6-99E2C1B52D13Q34583221-89CBA4DC-EA5D-45E5-8317-7B0CE7A9D1DBQ35740186-7C452FE3-ECB9-480A-AC3B-479B4A84D003Q36714774-4F390E4F-A15B-48FE-B158-4B329751FC47Q53239989-898F04B5-BA50-40B6-ACEF-215FA080C6F1Q54405940-EA89457C-3671-4BE6-9D6C-F4586BC21561Q54454685-D8B53D15-F1FE-4AA7-9D44-586D5715E7DCQ54577719-C2B6139B-A0DF-4E81-BC1E-F4BBF6DD448AQ54582564-79A74BE9-A54E-4CE0-B1E6-2B44EB9BE76EQ74646169-13E57AE5-8369-461F-A22D-B1BC7E065353Q79106208-14575634-FC47-422E-9EF4-26DEC95E52B4Q80184305-BD41C240-C9C6-43A5-879B-5972A746F142Q80307689-7673C9E9-80CB-4879-BAF0-3104CF933130Q80789780-2DF79552-7661-46B4-89B4-48049F787B3AQ81436256-BF24DD1C-CF5F-46D9-A08A-260529081580Q83357954-B2C7040A-9231-4E12-AC92-DE0F6241C168Q83475933-2882F49C-BA48-433A-ACF9-FA00F6FAC3EEQ83602657-8102F471-CD08-48A3-998B-3DFA7C7BAC4E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Teresa Cabrera
@ast
Teresa Cabrera
@en
Teresa Cabrera
@es
Teresa Cabrera
@nl
type
label
Teresa Cabrera
@ast
Teresa Cabrera
@en
Teresa Cabrera
@es
Teresa Cabrera
@nl
prefLabel
Teresa Cabrera
@ast
Teresa Cabrera
@en
Teresa Cabrera
@es
Teresa Cabrera
@nl
P106
P21
P31
P496
0000-0002-9871-1374